Hidden Traffic Podcast: Trade Law and Human Rights with Dean Pinkert
Hot Topics in International Trade. Braumiller Law Group Partner & Founder Adrienne Braumiller joins Vp of Marketing Bob Brewer for an Update on Forced Labor
Braumiller Law Group Help With China Imports
Third Party Ethical Audits
ESG: How Supply Chain Contracts Affect Human Rights - On Record PR
Hidden Traffic Podcast - The UN’s Stance on Business and Human Rights with Nate Lankford
Environmental Defender Romina Picolotti on Climate Justice and Human Rights
The Compliance Kitchen - OFAC issues Ethiopia Sanctions Regs
The ESG Report - Compliance and Human Rights Strategy
Season Two Trailer
Fraud Eats Strategy - Human Trafficking is Everyone’s Problem: Steps that Organizations Can Take to Disrupt Human Trafficking
2021 Employment Law Update: Part 12 – Tips and Trends for 2021 and 2022
WorldSmart: How Businesses Can Mitigate Risk of Forced Labor in Their Supply Chains
Leaders Moving Business Forward with Alphonso David of the Human Rights Campaign
JONES DAY TALKS®: Navigating Sanctions and Export Controls: A Guide for EMEA Businesses
Framing the American Past to Better Understand Women and Gender History with UC Davis Professors Ellen Hartigan -O’Conner and Lisa Materson: On Record PR
Book Discussion with Brittany Barnett, Author of A Knock at Midnight, and Tanya Eiserer (WFAA-TV)
Altering the Course of History for Women and Girls Around the World, with Latanya Mapp Frett, President and CEO of Global Fund for Women: On Record PR
Coronavirus in the Workplace
BLACK HISTORY MONTH | ELLA BAKER & MARY MCLEOD BETHUNE
Senate Judiciary Human Rights and the Law Subcommittee Holds Hearing on Georgia Abortion Ban. The field hearing examined how Georgia’s abortion ban impacts women’s health, and featured patient and physician witnesses. ...more
Mifepristone is safe for now. On June 13, 2024, the Supreme Court unanimously held that the plaintiffs — doctors and medical associations alike — lacked standing to challenge 2000 and 2019 FDA approvals of mifepristone (brand...more
The Big Picture - On December 13, 2023, the Supreme Court announced its intention to review the August 16 ruling by the Fifth Circuit in Alliance for Hippocratic Medicine (AHM) v. U.S. Food and Drug Administration, et al....more
The U.S. Food and Drug Administration (FDA) has written a letter to the manufacturers and developers of new plant varieties, urging them to fully consider the potential ramifications of transferring the genes of allergens to...more
As the European Union (“EU”) continues to debate whether downstream responsibilities will fall within the contours of its hefty Corporate Sustainability Mandatory Due Diligence Directive (“CSMDD”), and the EU Council just...more
The White House released its National Strategy on Hunger, Nutrition, and Health on Sept. 27, 2022, ahead of the second-ever White House Conference on Hunger, Nutrition, and Health. Specifically, the 44-page paper calls on...more
As the global economy faces the third year of the pandemic, manufacturers are no longer focused on figuring out when things will return to “normal.” Instead, they are applying lessons learned from the past few years to become...more
Earlier this month, the U.S. Food and Drug Administration (“FDA”) issued new guidance (“Guidance”) for sponsors, investigators, and institutional review boards (“IRBs”) regarding how recent changes to the Federal Policy for...more
On October 12, FDA published guidance for sponsors, investigators, and IRBs titled “Impact of Certain Provisions of the Revised Common Rule on FDA-Regulated Clinical Investigations.” ...more
As July comes to an end, the Food and Drug Administration (FDA or agency) has issued a new guidance document for “immediate implementation” entitled “IRB Waiver or Alteration of Informed Consent for Clinical Investigations...more
On January 19, 2017, sixteen federal agencies, including the Departments of Health and Human Services and Labor, published the first revision to the federal regulations governing the protection of human subjects participating...more
Proposals are Intended to Enhance Protections for Higher Risk Clinical Research and Privacy Safeguards, including Uses of Biospecimens and Identifiable Private Information - On September 8, 2015, the Department of Health...more
Leading the News - Burkina Faso: On September 17th, U.S. National Security Advisor Susan Rice condemned the unconstitutional seizure of power by elements of the Presidential Security Regiment in Burkina Faso and...more